Clinical Trial Update: Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated PF-4691502 in combination with letrozole versus letrozole alone in patients with breast cancer. The study was terminated and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• PF-4691502

Snippet

Sponsor: Pfizer | Conditions: Early Breast Cancer (Phase 2), Advanced Breast Cancer (Phase 1b) | Phase 2 | Status: TERMINATED | Results posted: 2014-08-12